Li Ning, Sood Sandeep, Wang Su, Fang Mingzhu, Wang Peng, Sun Zheng, Yang Chung S, Chen Xiaoxin
Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers-State University of New Jersey, 164 Frelinghuysen Road, Piscataway, NJ 08854, USA.
Clin Cancer Res. 2005 Mar 1;11(5):2089-96. doi: 10.1158/1078-0432.CCR-04-1684.
Previous studies have suggested an important role of aberrant arachidonic acid metabolism, especially the cyclooxygenase (Cox) pathway, in oral carcinogenesis. However, it is unknown whether the 5-lipoxygenase (5-Lox) pathway contributes to oral carcinogenesis, and whether combination of inhibitors of both pathways may have synergistic or additive effects of chemoprevention.
5-Lox expression was examined in 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster and human oral cancer tissues by immunohistochemistry, and Cox2 expression was investigated in hamster oral tissues using in situ hybridization. Zileuton (a specific 5-Lox inhibitor) and celecoxib (a specific Cox2 inhibitor), either alone or in combination, were investigated for their chemopreventive effects on the DMBA-induced hamster model at the post-initiation stage through topical application.
5-Lox was overexpressed during oral carcinogenesis in hamsters and humans, as well as Cox2 in the hamster tissues. In a chemoprevention study using the post-initiation DMBA model, incidence of hamster oral squamous cell carcinoma was reduced from 76.9% (20 of 26) to 45.8% (11 of 24, P < 0.05) and 32.1% (9 of 28, P < 0.01) by 3% and 6% topical zileuton, respectively; and to 57.6% (15 of 26, P > 0.05) and 50% (12 of 24, P < 0.05) by 3% and 6% topical celecoxib, respectively. When used in combination, celecoxib and zileuton (3% of each) had an additive inhibitory effect on the incidence of squamous cell carcinoma (36%, 9 of 25, P < 0.01). Other pathologic variables and the levels of leukotriene B4 and prostaglandin E2 of the hamster tissues were reduced as well.
The results clearly showed that both 5-Lox and Cox2 played important roles in oral carcinogenesis. Zileuton and celecoxib prevented oral carcinogenesis at the post-initiation stage through their inhibitory effects on arachidonic acid metabolism.
以往研究表明,异常的花生四烯酸代谢,尤其是环氧化酶(Cox)途径,在口腔癌发生过程中起重要作用。然而,5-脂氧合酶(5-Lox)途径是否参与口腔癌发生,以及这两条途径的抑制剂联合使用是否具有化学预防的协同或相加作用尚不清楚。
通过免疫组织化学检测7,12-二甲基苯并[a]蒽(DMBA)诱导的仓鼠和人类口腔癌组织中5-Lox的表达,并用原位杂交法研究仓鼠口腔组织中Cox2的表达。通过局部应用,研究齐留通(一种特异性5-Lox抑制剂)和塞来昔布(一种特异性Cox2抑制剂)单独或联合使用对DMBA诱导的仓鼠模型在启动后阶段的化学预防作用。
在仓鼠和人类口腔癌发生过程中5-Lox均过度表达,仓鼠组织中Cox2也过度表达。在使用启动后DMBA模型的化学预防研究中,3%和6%的局部齐留通分别将仓鼠口腔鳞状细胞癌的发生率从76.9%(26只中的20只)降至45.8%(24只中的11只,P<0.05)和32.1%(28只中的9只,P<0.01);3%和6%的局部塞来昔布分别将其降至57.6%(26只中的15只,P>0.05)和50%(24只中的12只,P<0.05)。联合使用时,塞来昔布和齐留通(各3%)对鳞状细胞癌的发生率具有相加抑制作用(36%,25只中的9只,P<0.01)。仓鼠组织的其他病理变量以及白三烯B4和前列腺素E2水平也降低了。
结果清楚地表明,5-Lox和Cox2在口腔癌发生中均起重要作用。齐留通和塞来昔布通过抑制花生四烯酸代谢在启动后阶段预防口腔癌发生。